FDA Panel Votes Against Boosters for All, Unanimously Recommends Them for Elderly and High-Risk Groups
On Friday, outside experts assembled by the Food and Drug Administration delivered a blow to the White House's ambition to roll out covid-19 booster doses to most Americans. The panel largely voted no on a recommendation to give third doses to vaccinated Americans over the age of 16. However, they did unanimously...